Rephonic
Artwork for Conversations in Drug Development

Conversations in Drug Development

Boyds
Drug Development
Regulatory Affairs
Clinical Trials
Patient Safety
Advanced Therapy Medicinal Products
Clinical Trials Regulation
Biotechnology
European Union
FDA
Investment Strategies
IND Process
Genetically Modified Organisms
Oncology
Phase I Clinical Trials
Data Rooms
Early Stage Funding
Pitch Decks
Genome Editing Technologies
Cell and Gene Therapy
Harmonization

Welcome to Conversations in Drug Development, brought to you by the team at Boyds for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development. This podcast series features candid conversations from the expert team at Boyds, who are at the forefront of cutting-edge science and drug development in the pharmaceutical and biotechno... more

PublishesInfrequentlyEpisodes22Founded2 years ago
Number of ListenersCategories
Life SciencesHealth & FitnessMedicineScience

Listen to this Podcast

Artwork for Conversations in Drug Development

Latest Episodes

In this special episode of Conversations in Drug Development, host Harriet Edwards sits down with Professor Alan Boyd, founder and CEO of Boyds, to reflect on the company’s remarkable 20-year journey in drug development.

Professor Boyd shares his ex... more

In the latest episode of Conversations in Drug Development, Dr Katherine Bowen and Dr Eric Hardter discuss the ever-changing US regulatory landscape under the new administration, including new leadership and staff turnover, and their impact on drug d... more

In this episode, Dr Neil Fish and Dr Ami Patel dive into the real-world challenges of drug development - from early-stage planning to regulatory hurdles and everything in between. Drawing on decades of experience, they share personal stories and expe... more

In this episode, Harriet Edwards from Boyds hosts a discussion on 2025 predictions in drug development and regulatory affairs. Joined by regulatory experts Dr. Katherine Bowen and Dr. Eric Hartder, the conversation covers the anticipated trends in th... more

Key Facts

Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Chris Moore
Clinical Project Manager at Boyds
Boyds
Episode: Patients as Partners: Advocacy's Role in Shaping Drug Development
Katherine Bowen
Regulatory Affairs team member at Boyds
Boyds
Episode: Navigating the new EU Clinical Trials Regulation
Shalini Gupta
Senior Manager of Regulatory Affairs at Boyds
Boyds
Episode: Navigating the new EU Clinical Trials Regulation
Monica Pianella
Regulatory Expert for Advanced Therapies
Boyds
Episode: Advances in Cell-Based Immunotherapies: CAR-T Cell Therapy vs TCR Therapy
Dr. Sabine Ruehle
Part of the regulatory team at Boyds and a resident expert on GMOs.
Boyds
Episode: How are GMO Regulations Impacting Clinical Development in Europe?

Host

Harriet Edwards
Host of Conversations in Drug Development and part of the Regulatory Team at Boyds.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Navigating the new EU Clinical Trials Regulation
Q: What are the main challenges the regulation introduced?
Challenges include managing modifications to trial documentation, the transition from the old system to the new CTR, and ensuring that transparency requirements don't compromise confidential information.
Navigating the new EU Clinical Trials Regulation
Q: How has the regulation impacted patients?
The regulation has enhanced safety standards, increased transparency, improved informed consent processes, and allowed patient involvement in trial design, making trials more relevant for them.
Navigating the new EU Clinical Trials Regulation
Q: How has the regulation impacted clinical research in the EU so far?
The regulation has transformed clinical trial processes, drastically improving trial authorization times and facilitating multinational trials, with a significant increase in submissions since its implementation.
The Most Essential Tips for Biotechs Seeking Investment
Q: What are dos and don'ts for a corporate website?
The website should be professionally made, informative, and kept up to date as it's often the first touchpoint for investors.
The Most Essential Tips for Biotechs Seeking Investment
Q: How should the content of the pitch deck be structured?
The slides need the right amount of science for the audience while also addressing the unmet medical need and product efficacy without overwhelming listeners with technical details.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Conversations in Drug Development

What is Conversations in Drug Development about and what kind of topics does it cover?

This podcast provides insightful discussions surrounding the complexities and innovations within the realms of drug development, particularly focusing on cell and gene therapies and regulatory affairs. Through engaging dialogues with industry experts, the content frequently addresses pivotal topics such as regulatory processes, clinical trials, and patient engagement in drug development, emphasizing the significance of keeping patients' voices at the forefront. Additionally, the series often explores the implications of new regulations, advanced therapeutic products, and collaborative efforts needed to shape the future of medical advancements. Unique to this offering is the blend of real-world insights from practitioners who are deeply entr... more

Where can I find podcast stats for Conversations in Drug Development?

Rephonic provides a wide range of podcast stats for Conversations in Drug Development. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Conversations in Drug Development and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Conversations in Drug Development get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Conversations in Drug Development, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Conversations in Drug Development?

Rephonic provides comprehensive predictive audience data for Conversations in Drug Development, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Conversations in Drug Development have?

To see how many followers or subscribers Conversations in Drug Development has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Conversations in Drug Development?

These podcasts share a similar audience with Conversations in Drug Development:

1. BioCentury This Week
2. The Readout Loud
3. Worklife with Adam Grant
4. Think Fast Talk Smart: Communication Techniques
5. NEJM This Week

How many episodes of Conversations in Drug Development are there?

Conversations in Drug Development launched 2 years ago and published 22 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Conversations in Drug Development?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Conversations in Drug Development?

Rephonic pulls ratings and reviews for Conversations in Drug Development from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Conversations in Drug Development?

Rephonic provides full transcripts for episodes of Conversations in Drug Development. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Conversations in Drug Development?

Recent guests on Conversations in Drug Development include:

1. Chris Moore
2. Katherine Bowen
3. Shalini Gupta
4. Monica Pianella
5. Dr. Sabine Ruehle

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days